Venice Film Festival: The Web Series Artitude Created by Pomilio Blumm Receives an Award for Promoting the Made in Italy Brand

Lorenzo Balbi at the Venice Film Festival VENICE, Italy, Sept. 12, 2022 (GLOBE NEWSWIRE) — The prize awarded to the web series Artitude was presented in Venice as part of the Film Festival. The Social World Film Festival jury’s special plaque for the project created by Pomilio Blumm was received by Lorenzo Balbi, director of MAMbo (Museum […]

Mecobit Mining Rigs Announces the Biggest Hash-Rate in the Market

LONDON, Sept. 12, 2022 (GLOBE NEWSWIRE) — MECO Limited (Mecobit), one of the world’s leading manufacturers of solar modules and complete solutions, recently launched new products Solar Unit M4000, Solar Panel Kit (complete), Portable Power Station, M100 Miner, M200 Miner, Meco Rack, which has attracted wide attention in the industry. The result of five years […]

Neeyamo’s Global Screening Services is Now ScreenXchange – an Independent Business Unit Poised for Tremendous Growth

ScreenXchange provides a superior screening experience courtesy of its peerless delivery model. LOS GATOS, Calif., Sept. 12, 2022 (GLOBE NEWSWIRE) — Success in a rapidly evolving borderless business environment requires bleeding-edge employee screening to ensure you have the right talent with validated credentials that mitigates organizations from potential risks. Neeyamo is elated to announce the […]

Truth and justice: A conversation with the families of Flight PS752 victims

WASHINGTON, Sept. 12, 2022 (GLOBE NEWSWIRE) — When: 1:00 p.m. ET on Wednesday, September 14, 2022 Where: 1030 15th Street, NW, 12th Floor Washington, DC 20005 Registration and virtual attendance available via the link below: https://www.atlanticcouncil.org/event/truth-and-justice-a-conversation-with-the-families-of-flight-ps752-victims/ What: The Association of Families of Flight PS752 Victims (the Association) will be participating in a discussion hosted by […]

Algernon Pharmaceuticals Receives Approval for Groundbreaking Phase 1 DMT Human Stroke Study

VANCOUVER, British Columbia, Sept. 12, 2022 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) a clinical stage pharmaceutical development company is pleased to announce that it has received approval to conduct a Phase 1 clinical study of an intravenous formulation (“IVF”) of AP-188 (“N,N-dimethyl tryptamine” or “DMT”) for […]